leuprolide acetate
NDC 0121-2106, leuprolide acetate, kit, from PAI Holdings, LLC dba PAI Pharma.
- Product NDC
- 0121-2106
- Status
- Listed
- Labeler
- PAI Holdings, LLC dba PAI Pharma
- Dosage form
- KIT
- Route
- SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA217957
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0121-2106 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
None listed.
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0121-2106-02 | 00121210602 | 1 KIT in 1 CARTON (0121-2106-02) * 1 VIAL, MULTI-DOSE in 1 CARTON (0121-1053-02) / 2.8 mL in 1 VIAL, MULTI-DOSE * 1 mL in 1 PACKET (0121-2105-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/19be0b7f-e68a-4547-9e49-b51b12821907NADAC price for package 00121210602
GET /v1/drugs/nadac/00121210602
Use it
Look up 0121-2106 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0121-2106 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0121-2106. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.